Tirzepatide 10mg

Tirzepatide is a novel, once-weekly injectable peptide (dual GIP and GLP-1 receptor agonist) approved for type 2 diabetes (as Mounjaro) and chronic weight management (as Zepbound). It improves blood sugar, boosts insulin sensitivity, and significantly reduces body weight and fat mass by suppressing appetite and slowing gastric emptying. Common side effects include nausea, diarrhea, constipation, and abdominal pain.